Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study.

Publikation

Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study.

Wissenschaftlicher Artikel/Review - 21.05.2014

Pugin Deborah, Foreman Brandon, De Marchis Gian Marco, Fernandez Andres, Sanchez Schmidt J M, Czeisler Barry M, Mayer Stephan A, Agarwal Sachin, Lesch Christine, Lantigua Hector, Claassen Jan

Zitation

Pugin D, Foreman B, De Marchis G, Fernandez A, Sanchez Schmidt J, Czeisler B, Mayer S, Agarwal S, Lesch C, Lantigua H, Claassen J. Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study. Crit Care 2014; 18:R103.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Crit Care 2014; 18

Veröffentlichungsdatum

21.05.2014

eISSN (Online)

1466-609X

Seiten

R103

Kurzbeschreibung/Zielsetzung

Seizures refractory to third-line therapy are also labeled super-refractory status epilepticus (SRSE). These seizures are extremely difficult to control and associated with poor outcome. We aimed to characterize efficacy and side-effects of continuous infusions of pentobarbital (cIV-PTB) treating SRSE.